home / stock / hae / hae articles
Chemed Corporation (NYSE: CHE) is primed to grow in the upcoming quarters, backed by the promising prospects of the VITAS business. The compan...
Quest Diagnostics (NYSE: DGX) recently announced a definitive agreement to purchase the select assets of OhioHealth's outreach laboratory servi...
The Zacks Medical – Products industry's revenues are expected to continue its growth trajectory on the back of the recovery in demand for...
Needham & Co. analyst Mike Matson upgraded Haemonetics Corporation (NYSE:HAE) from Hold to Buy with a price target of $112. The analyst says th...
Haemonetics Corporation‘s (NYSE: HAE) shares have increased 10.8% year to date compared with the industry's rise of 6.1%. The Medical sec...
News, Short Squeeze, Breakout and More Instantly...
Haemonetics Corporation Company Name:
HAE Stock Symbol:
NYSE Market:
Haemonetics Corporation Website:
2024-07-08 21:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 PR Newswire BOSTON , July 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financia...
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device PR Newswire BOSTON , June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions ...